14.99
6.24%
0.88
Arcutis Biotherapeutics Inc (ARQT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
266.47%
49.57
|
13.53 | 38.11 | 5.19 | 2.781 |
Cost Of Revenue |
3.256
|
- | - | - | - |
Gross Profit |
46.31
|
- | - | - | - |
Operating Expenses
|
11.80%
77.94
|
69.71 | 75.01 | 71.95 | 79.05 |
Interest Income/Expense |
3.63%
7.48
|
7.762 | 7.559 | 7.349 | 7.042 |
Benefits Costs and Expenses |
73.00%
81.19
|
300.71 | - | - | - |
Costs And Expenses |
8.70%
81.19
|
74.69 | 75.01 | 71.95 | 79.05 |
Operating Income/Loss |
48.30%
-31.62
|
-61.17 | -36.90 | -66.76 | -76.27 |
Income/Loss From Continuing Operations Before Tax |
88.99%
-31.62
|
-287.18 | 38.11 | -70.99 | -80.10 |
Income Tax Expense/Benefit |
1,196%
0.324
|
0.025 | 3.023 | - | - |
Income/Loss From Continuing Operations After Tax |
46.62%
-35.38
|
-66.28 | -44.77 | -70.99 | -80.10 |
Net Income/Loss
|
46.62%
-35.38
|
-66.28 | -44.77 | -70.99 | -80.10 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
1,316%
111.05
|
7.8435 | 61.73 | 61.43 | 61.17 |
Diluted Average Shares |
1,316%
111.05
|
7.8435 | 61.73 | 61.43 | 61.17 |
Basic Earnings Per Share |
45.76%
-0.32
|
-0.59 | -0.73 | -1.16 | -1.31 |
Diluted Earnings Per Share |
45.76%
-0.32
|
-0.59 | -0.73 | -1.16 | -1.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):